{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:12:26Z","timestamp":1790622746665,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,10,15]],"date-time":"2013-10-15T00:00:00Z","timestamp":1381795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,10,15]],"date-time":"2013-10-15T00:00:00Z","timestamp":1381795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1038\/tpj.2013.30","type":"journal-article","created":{"date-parts":[[2013,10,15]],"date-time":"2013-10-15T09:54:13Z","timestamp":1381830853000},"page":"303-308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females"],"prefix":"10.1038","volume":"14","author":[{"given":"T-K","family":"Clarke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R C","family":"Crist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Ambrose-Lanci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F W","family":"Lohoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M P","family":"Hillhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R D","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Woody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W H","family":"Berrettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,15]]},"reference":[{"key":"BFtpj201330_CR1","unstructured":"Administration SAaMHS. Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-44. 2010;HHS Publication No. (SMA) 12-4713."},{"issue":"1 Suppl B","key":"BFtpj201330_CR2","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.18553\/jmcp.2010.16.S1-B.14","volume":"16","author":"L Nicholls","year":"2010","unstructured":"Nicholls L, Bragaw L, Ruetsch C . Opioid dependence treatment and guidelines. J Manag Care Pharm 2010; 16 (1 Suppl B): S14\u2013S21.","journal-title":"J Manag Care Pharm"},{"key":"BFtpj201330_CR3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1254\/jjp.88.319","volume":"88","author":"JJ Rady","year":"2002","unstructured":"Rady JJ, Portoghese PS, Fujimo JM . Methadone and heroin antinociception: predominant delta-opioid-receptor responses in methadone-tolerant mice. Jap J Pharmacol 2002; 88: 319\u2013331.","journal-title":"Jap J Pharmacol"},{"key":"BFtpj201330_CR4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00008877-200211000-00005","volume":"13","author":"SS Negus","year":"2002","unstructured":"Negus SS, Bidlack JM, Mello NK, Furness MS, Rice KC, Brandt MR . Delta opioid antagonist effects of buprenorphine in rhesus monkeys. Behav Pharmacol 2002; 13: 557\u2013570.","journal-title":"Behav Pharmacol"},{"key":"BFtpj201330_CR5","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1097\/00001756-199707280-00025","volume":"8","author":"P Mayer","year":"1997","unstructured":"Mayer P, Rochlitz H, Rauch E, Rommelspacher H, Hasse HE, Schmidt S et al. Association between a delta opioid receptor gene polymorphism and heroin dependence in man. Neuroreport 1997; 8: 2547\u20132550.","journal-title":"Neuroreport"},{"key":"BFtpj201330_CR6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.mp.4002035","volume":"13","author":"H Zhang","year":"2008","unstructured":"Zhang H, Kranzler HR, Yang BZ, Luo X, Gelernter J . The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Mol Psychiatry 2008; 13: 531\u2013543.","journal-title":"Mol Psychiatry"},{"key":"BFtpj201330_CR7","doi-asserted-by":"crossref","unstructured":"Nelson EC, Lynskey MT, Heath AC, Wray N, Agrawal A, Shand FL et al. Association of OPRD1 polymorphisms with heroin dependence in a large case-control series. Addiction Biol 2012, doi: 10.1111\/j.1369-1600.2012.00445.x (e-pub ahead of print).","DOI":"10.1111\/j.1369-1600.2012.00445.x"},{"key":"BFtpj201330_CR8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1601-183X.2008.00410.x","volume":"7","author":"O Levran","year":"2008","unstructured":"Levran O, Londono D, O'Hara K, Nielsen DA, Peles E, Rotrosen J et al. Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain Behav 2008; 7: 720\u2013729.","journal-title":"Genes Brain Behav"},{"key":"BFtpj201330_CR9","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/(SICI)1096-8628(19991015)88:5<462::AID-AJMG4>3.0.CO;2-S","volume":"88","author":"P Franke","year":"1999","unstructured":"Franke P, Nothen MM, Wang T, Neidt H, Knapp M, Lichtermann D et al. Human delta-opioid receptor gene and susceptibility to heroin and alcohol dependence. Am J Med Genet 1999; 88: 462\u2013464.","journal-title":"Am J Med Genet"},{"key":"BFtpj201330_CR10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajmg.10374","volume":"110","author":"K Xu","year":"2002","unstructured":"Xu K, Liu XH, Nagarajan S, Gu XY, Goldman D . Relationship of the delta-opioid receptor gene to heroin abuse in a large Chinese case\/control sample. Am J Med Genet 2002; 110: 45\u201350.","journal-title":"Am J Med Genet"},{"key":"BFtpj201330_CR11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/ajmg.b.30531","volume":"144B","author":"X Xuei","year":"2007","unstructured":"Xuei X, Flury-Wetherill L, Bierut L, Dick D, Nurnberger J Jr., Foroud T et al. The opioid system in alcohol and drug dependence: family-based association study. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 877\u2013884.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BFtpj201330_CR12","doi-asserted-by":"crossref","unstructured":"Mattick RP, Kimber J, Breen C, Davoli M . Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev (Online) 2008: CD002207.","DOI":"10.1002\/14651858.CD002207.pub3"},{"key":"BFtpj201330_CR13","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/jama.286.14.1724","volume":"286","author":"DA Fiellin","year":"2001","unstructured":"Fiellin DA, O'Connor PG, Chawarski M, Pakes JP, Pantalon MV, Schottenfeld RS . Methadone maintenance in primary care: a randomized controlled trial. JAMA 2001; 286: 1724\u20131731.","journal-title":"JAMA"},{"key":"BFtpj201330_CR14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jpainsymman.2004.07.005","volume":"29","author":"RE Johnson","year":"2005","unstructured":"Johnson RE, Fudala PJ, Payne R . Buprenorphine: considerations for pain management. J Pain Symptom Mmanag 2005; 29: 297\u2013326.","journal-title":"J Pain Symptom Mmanag"},{"key":"BFtpj201330_CR15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archpsyc.1996.01830050035005","volume":"53","author":"W Ling","year":"1996","unstructured":"Ling W, Wesson DR, Charuvastra C, Klett CJ . A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry 1996; 53: 401\u2013407.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtpj201330_CR16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(00)80006-X","volume":"60","author":"PP Pani","year":"2000","unstructured":"Pani PP, Maremmani I, Pirastu R, Tagliamonte A, Gessa GL . Buprenorphine: a controlled clinical trial in the treatment of opioid dependence. Drug Alcohol Depend 2000; 60: 39\u201350.","journal-title":"Drug Alcohol Depend"},{"key":"BFtpj201330_CR17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(00)00163-0","volume":"62","author":"S Petitjean","year":"2001","unstructured":"Petitjean S, Stohler R, Deglon JJ, Livoti S, Waldvogel D, Uehlinger C et al. Double-blind randomized trial of buprenorphine and methadone in opiate dependence. Drug Alcohol Depend 2001; 62: 97\u2013104.","journal-title":"Drug Alcohol Depend"},{"key":"BFtpj201330_CR18","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jama.281.11.1000","volume":"281","author":"EC Strain","year":"1999","unstructured":"Strain EC, Bigelow GE, Liebson IA, Stitzer ML . Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA 1999; 281: 1000\u20131005.","journal-title":"JAMA"},{"key":"BFtpj201330_CR19","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1997.tb02854.x","volume":"92","author":"M del Rio","year":"1997","unstructured":"del Rio M, Mino A, Perneger TV . Predictors of patient retention in a newly established methadone maintenance treatment programme. Addiction (Abingdon, England) 1997; 92: 1353\u20131360.","journal-title":"Addiction (Abingdon, England)"},{"key":"BFtpj201330_CR20","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/bmj.309.6960.997","volume":"309","author":"M Farrell","year":"1994","unstructured":"Farrell M, Ward J, Mattick R, Hall W, Stimson GV, des Jarlais D et al. Methadone maintenance treatment in opiate dependence: a review. BMJ 1994; 309: 997\u20131001.","journal-title":"BMJ"},{"key":"BFtpj201330_CR21","first-page":"393","volume":"100","author":"F Kamal","year":"2007","unstructured":"Kamal F, Flavin S, Campbell F, Behan C, Fagan J, Smyth R . Factors affecting the outcome of methadone maintenance treatment in opiate dependence. Irish Med J 2007; 100: 393\u2013397.","journal-title":"Irish Med J"},{"issue":"Suppl 1","key":"BFtpj201330_CR22","first-page":"S70","volume":"38","author":"LT Wu","year":"2010","unstructured":"Wu LT, Pan JJ, Blazer DG, Tai B, Stitzer ML, Woody GE . Using a latent variable approach to inform gender and racial\/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study. J Subst Abuse Treat 2010; 38 (Suppl 1): S70\u2013S79.","journal-title":"J Subst Abuse Treat"},{"key":"BFtpj201330_CR23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/00952990.2011.596982","volume":"37","author":"SE Back","year":"2011","unstructured":"Back SE, Payne RL, Wahlquist AH, Carter RE, Stroud Z, Haynes L et al. Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial. Am J Drug Alcohol Abuse 2011; 37: 313\u2013323.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"BFtpj201330_CR24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.drugalcdep.2004.02.001","volume":"74","author":"CA Hernandez-Avila","year":"2004","unstructured":"Hernandez-Avila CA, Rounsaville BJ, Kranzler HR . Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend 2004; 74: 265\u2013272.","journal-title":"Drug Alcohol Depend"},{"key":"BFtpj201330_CR25","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3109\/10826088509056356","volume":"20","author":"TR Kosten","year":"1985","unstructured":"Kosten TR, Rounsaville BJ, Kleber HD . Ethnic and gender differences among opiate addicts. Int J Addict 1985; 20: 1143\u20131162.","journal-title":"Int J Addict"},{"key":"BFtpj201330_CR26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.drugalcdep.2011.03.024","volume":"118","author":"DE Moody","year":"2011","unstructured":"Moody DE, Fang WB, Morrison J, McCance-Katz E . Gender differences in pharmacokinetics of maintenance dosed buprenorphine. Drug Alcohol Depend 2011; 118: 479\u2013483.","journal-title":"Drug Alcohol Depend"},{"key":"BFtpj201330_CR27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1213\/ane.0b013e31816a66a4","volume":"107","author":"A Dahan","year":"2008","unstructured":"Dahan A, Kest B, Waxman AR, Sarton E . Sex-specific responses to opiates: animal and human studies. Anesth Analg 2008; 107: 83\u201395.","journal-title":"Anesth Analg"},{"key":"BFtpj201330_CR28","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/00000542-200011000-00018","volume":"93","author":"E Sarton","year":"2000","unstructured":"Sarton E, Olofsen E, Romberg R, den Hartigh J, Kest B, Nieuwenhuijs D et al. Sex differences in morphine analgesia: an experimental study in healthy volunteers. Anesthesiology 2000; 93: 1245\u20131254, discussion 6A.","journal-title":"Anesthesiology"},{"key":"BFtpj201330_CR29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00000542-200507000-00023","volume":"103","author":"F Aubrun","year":"2005","unstructured":"Aubrun F, Salvi N, Coriat P, Riou B . Sex- and age-related differences in morphine requirements for postoperative pain relief. Anesthesiology 2005; 103: 156\u2013160.","journal-title":"Anesthesiology"},{"key":"BFtpj201330_CR30","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1213\/01.ANE.0000080153.36643.83","volume":"97","author":"MS Cepeda","year":"2003","unstructured":"Cepeda MS, Carr DB . Women experience more pain and require more morphine than men to achieve a similar degree of analgesia. Anesth Analg 2003; 97: 1464\u20131468.","journal-title":"Anesth Analg"},{"key":"BFtpj201330_CR31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0304-3940(96)12402-2","volume":"205","author":"RW Gear","year":"1996","unstructured":"Gear RW, Gordon NC, Heller PH, Paul S, Miaskowski C, Levine JD . Gender difference in analgesic response to the kappa-opioid pentazocine. Neurosci Lett 1996; 205: 207\u2013209.","journal-title":"Neurosci Lett"},{"key":"BFtpj201330_CR32","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm1196-1248","volume":"2","author":"RW Gear","year":"1996","unstructured":"Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, Levine JD . Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med 1996; 2: 1248\u20131250.","journal-title":"Nat Med"},{"key":"BFtpj201330_CR33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0304-3959(99)00119-0","volume":"83","author":"RW Gear","year":"1999","unstructured":"Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, Levine JD . The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain. Pain 1999; 83: 339\u2013345.","journal-title":"Pain"},{"key":"BFtpj201330_CR34","doi-asserted-by":"crossref","first-page":"20115","DOI":"10.1073\/pnas.1009923107","volume":"107","author":"S Chakrabarti","year":"2010","unstructured":"Chakrabarti S, Liu NJ, Gintzler AR . Formation of mu-\/kappa-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia. Proc Natl Acad Sci USA 2010; 107: 20115\u201320119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtpj201330_CR35","doi-asserted-by":"crossref","first-page":"11836","DOI":"10.1523\/JNEUROSCI.1901-11.2011","volume":"31","author":"NJ Liu","year":"2011","unstructured":"Liu NJ, Chakrabarti S, Schnell S, Wessendorf M, Gintzler AR . Spinal synthesis of estrogen and concomitant signaling by membrane estrogen receptors regulate spinal kappa- and mu-opioid receptor heterodimerization and female-specific spinal morphine antinociception. J Neurosci 2011; 31: 11836\u201311845.","journal-title":"J Neurosci"},{"key":"BFtpj201330_CR36","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/npp.2013.99","volume":"38","author":"R Crist","year":"2013","unstructured":"Crist R, Clarke T, Ang A, Ambrose-Lanci LM, Lohoff F, Saxon AJ et al. An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans. Neuropsychopharmacology 2013; 38: 2003\u20132010.","journal-title":"Neuropsychopharmacology"},{"key":"BFtpj201330_CR37","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/tpj.2010.37","volume":"11","author":"B Oneda","year":"2011","unstructured":"Oneda B, Crettol S, Bochud M, Besson J, Croquette-Krokar M, Hammig R et al. beta-Arrestin2 influences the response to methadone in opioid-dependent patients. Pharmacogenomics J 2011; 11: 258\u2013266.","journal-title":"Pharmacogenomics J"},{"key":"BFtpj201330_CR38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drugalcdep.2012.08.002","volume":"128","author":"AJ Saxon","year":"2012","unstructured":"Saxon AJ, Ling W, Hillhouse M, Thomas C, Hasson A, Ang A et al. Buprenorphine\/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial. Drug Alcohol Depend 2012 Aug 22; 128: 71\u201376.","journal-title":"Drug Alcohol Depend"},{"key":"BFtpj201330_CR39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett JC, Fry B, Maller J, Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England) 2005; 21: 263\u2013265.","journal-title":"Bioinformatics (Oxford, England)"},{"key":"BFtpj201330_CR40","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559\u2013575.","journal-title":"Am J Hum Genet"},{"key":"BFtpj201330_CR41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","volume":"125","author":"Y Benjamini","year":"2001","unstructured":"Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I . Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001; 125: 279\u2013284.","journal-title":"Behav Brain Res"},{"key":"BFtpj201330_CR42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","volume":"73","author":"KYZ Liang","year":"1986","unstructured":"Liang KYZ . Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13\u201322.","journal-title":"Biometrika"},{"key":"BFtpj201330_CR43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/00952998709001500","volume":"13","author":"MD Anglin","year":"1987","unstructured":"Anglin MD, Hser YI, McGlothlin WH . Sex differences in addict careers. 2. Becoming addicted. Am J Drug Alcohol Abuse 1987; 13: 59\u201371.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"BFtpj201330_CR44","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3109\/10826089309062178","volume":"28","author":"D Longshore","year":"1993","unstructured":"Longshore D, Hsieh S, Danila B, Anglin MD . Methadone maintenance and needle\/syringe sharing. Int J Addict 1993; 28: 983\u2013996.","journal-title":"Int J Addict"},{"key":"BFtpj201330_CR45","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1176\/ajp.156.6.842","volume":"156","author":"JK Zubieta","year":"1999","unstructured":"Zubieta JK, Dannals RF, Frost JJ . Gender and age influences on human brain mu-opioid receptor binding measured by PET. Am J Psychiatry 1999; 156: 842\u2013848.","journal-title":"Am J Psychiatry"},{"key":"BFtpj201330_CR46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2008.02.105","volume":"1210","author":"LM Ambrose-Lanci","year":"2008","unstructured":"Ambrose-Lanci LM, Peiris NB, Unterwald EM, Van Bockstaele EJ . Cocaine withdrawal-induced trafficking of delta-opioid receptors in rat nucleus accumbens. Brain Res 2008; 1210: 92\u2013102.","journal-title":"Brain Res"},{"key":"BFtpj201330_CR47","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/sj.npp.1300934","volume":"31","author":"C Contet","year":"2006","unstructured":"Contet C, Gaveriaux-Ruff C, Matifas A, Caradec C, Champy MF, Kieffer BL . Dissociation of analgesic and hormonal responses to forced swim stress using opioid receptor knockout mice. Neuropsychopharmacology 2006; 31: 1733\u20131744.","journal-title":"Neuropsychopharmacology"},{"key":"BFtpj201330_CR48","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1210\/me.2003-0441","volume":"18","author":"V Bourdeau","year":"2004","unstructured":"Bourdeau V, Deschenes J, Metivier R, Nagai Y, Nguyen D, Bretschneider N et al. Genome-wide identification of high-affinity estrogen response elements in human and mouse. Mol Endocrinol Baltimore, MD 2004; 18: 1411\u20131427.","journal-title":"Mol Endocrinol Baltimore, MD"},{"key":"BFtpj201330_CR49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0026-895X(25)13131-3","volume":"44","author":"MM Belcheva","year":"1993","unstructured":"Belcheva MM, Barg J, McHale RJ, Dawn S, Ho MT, Ignatova E et al. Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine. Mol Pharmacol 1993; 44: 173\u2013179.","journal-title":"Mol Pharmacol"},{"key":"BFtpj201330_CR50","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/S0022-3565(25)13078-4","volume":"277","author":"MM Belcheva","year":"1996","unstructured":"Belcheva MM, Ho MT, Ignatova EG, Jefcoat LB, Barg J, Vogel Z et al. Buprenorphine differentially alters opioid receptor adaptation in rat brain regions. J Pharmacol Exp Ther 1996; 277: 1322\u20131327.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFtpj201330_CR51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1254\/jjp.40.95","volume":"40","author":"M Kajiwara","year":"1986","unstructured":"Kajiwara M, Aoki K, Ishii K, Numata H, Matsumiya T, Oka T . Agonist and antagonist actions of buprenorphine on three types of opioid receptor in isolated preparations. Jap J Pharmacol 1986; 40: 95\u2013101.","journal-title":"Jap J Pharmacol"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tpj201330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201330","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T17:07:40Z","timestamp":1746032860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tpj201330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,15]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["BFtpj201330"],"URL":"https:\/\/doi.org\/10.1038\/tpj.2013.30","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,15]]},"assertion":[{"value":"15 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AJ Saxon is a paid consultant to Reckitt Benckiser Pharmaceuticals; W Ling is a paid consultant to Reckitt Benckiser Pharmaceuticals; RD Bruce research grant was supported by Gilead Sciences, Merck, Bristol Myers Squibb, Boehringer Ingelheim, Reckitt Benckiser Pharmaceuticals, Abbott Laboratories, Pfizer and honorarium from Reckitt Benckiser Pharmaceuticals. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}